Active, not recruitingNCT04529252
Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
Studying Spinocerebellar ataxia type 42
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Zbigniew K Wszolek, MDMayo Clinic
- Intervention
- Specimen collection(other)
- Enrollment
- 1000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2026
Study locations (1)
- Mayo Clinic in Florida, Jacksonville, Florida, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04529252 on ClinicalTrials.gov